Publications by authors named "Shaochen Guo"

Claim this Profile
E
Exploring the anti-tuberculosis activity mechanism of OTB-658: Multi-omics analysis.
Qiyue Jia, Shaochen Guo, Bin Wang, Hui Zhu, Yu Lu

J Pharm Biomed Anal· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activities of a novel benzothiopyranone candidate NTB-3119M against Mycobacterium tuberculosis.
Manyi Xu, Lei Zhang, Bin Wang, Lei Fu, Shaochen Guo

Tuberculosis (Edinb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
is associated with clofazimine resistance in .
Lei Zhang, Ye Zhang, Yuanyuan Li, Fengmin Huo, Xi Chen, Shaochen Guo

Microbiol Spectr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models.
Haiting Liu, Hui Zhu, Lei Fu, Weiyan Zhang, Xi Chen, Shaochen Guo

Antimicrob Agents Chemother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis.
Yangming Ding, Hui Zhu, Lei Fu, Weiyan Zhang, Bin Wang, Shaochen Guo

Antimicrob Agents Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
Ning Wang, Shaochen Guo, Haiting Liu, Yangming Ding, Rong Yao

Xenobiotica· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis.
Shaochen Guo, Bin Wang, Lei Fu, Xi Chen, Weiyan Zhang

Antimicrob Agents Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
Shaochen Guo, Lei Fu, Bin Wang, Xi Chen, Jiaojie Zhao

Biomed Pharmacother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from in vitro.
Minghao Hu, Lei Fu, Bin Wang, Jian Xu, Shaochen Guo

Infect Drug Resist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Regimens Containing TBI-166, a New Drug Candidate against and .
Ye Zhang, Hui Zhu, Lei Fu, Bin Wang, Shaochen Guo

Antimicrob Agents Chemother· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Activities of the Riminophenazine TBI-166 against .
Jian Xu, Bin Wang, Lei Fu, Hui Zhu, Shaochen Guo

Antimicrob Agents Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum vitamin D level and vitamin D receptor genotypes may be associated with tuberculosis clinical characteristics: A case-control study.
Ye Zhang, Hui Zhu, Xinting Yang, Shaochen Guo, Qingtao Liang

Medicine (Baltimore)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
Jian Xu, Bin Wang, Minghao Hu, Fengmin Huo, Shaochen Guo

Antimicrob Agents Chemother· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability of rifampicin in four Chinese fixed-dose combinations compared with rifampicin in free combinations.
Hui Zhu, Shao-Chen Guo, Lan-Hu Hao, Cheng-Cheng Liu, Bin Wang

Chin Med J (Engl)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of advanced glycation end product formation by Pu-erh tea ameliorates progression of experimental diabetic nephropathy.
Shi-Jun Yan, Lei Wang, Zhi Li, Di-Na Zhu, Shao-Chen Guo

J Agric Food Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis